AcelRx Pharmaceuticals' IPO

AcelRx Pharmaceuticals raised a round of funding on February 11, 2011. Investors include Public.

AcelRx Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of acute and breakthrough pain. AcelRx's lead product candi…

Articles about AcelRx Pharmaceuticals' IPO: